Glofitamab Regimen Improves Survival in DLBCL

Published Date: 24 Jun 2024

Granted accelerated approval last year, bispecific antibody passes its confirmatory test

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GLP-1 receptor agonists, cancer risk and questionable significance

2.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

3.

The risk of cancer is decreased by following international health recommendations.

4.

AI is equally capable of reading breast cancer scans as human radiologists.

5.

Discovery of estrogen receptor 'switches' may aid breast cancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot